The combination of antiagniogenic agents to inhibit primary tumor growth and metastasis
- 1 October 1993
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 28 (10) , 1253-1257
- https://doi.org/10.1016/s0022-3468(05)80308-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- Mechanisms of Endothelial Growth ControlAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in MiceJNCI Journal of the National Cancer Institute, 1989
- What is the role of angiogenesis in metastasis from cutaneous melanoma?European Journal of Cancer and Clinical Oncology, 1987
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971